Horizon Financial Services, LLC Mi Nk Therapeutics, Inc. Transaction History

Horizon Financial Services, LLC

  • $229 Million
  • Q4 2025

A detailed history of Horizon Financial Services, LLC transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Horizon Financial Services, LLC holds 160 shares of INKT stock, worth $2,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Holding current value
$2,044
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026
BUY
$12.78 - $15.46 $2,044 - $2,473
160 New
160 $2,000

Others Institutions Holding INKT

# of Institutions
4
Shares Held
89.4K
Call Options Held
0
Put Options Held
0
View Full List

About MiNK Therapeutics, Inc.

INKT Quotes by TradingView
  • Ticker INKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,775,100
  • Market Cap $432M
  • Description
  • MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...
More about INKT
Track This Portfolio

Track Horizon Financial Services, LLC Portfolio

Follow Horizon Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email